Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: results of radiation therapy oncology group trial 93-12. (Q33333637)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: results of radiation therapy oncology group trial 93-12. |
scientific article |
Statements
1 reference
Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: results of radiation therapy oncology group trial 93-12. (English)
1 reference
B Glisson
1 reference
C Scott
1 reference
R Komaki
1 reference
B Movsas
1 reference
H Wagner
1 reference
1 August 2000
1 reference
1 reference
18
1 reference
16
1 reference
2990-2995
1 reference
Identifiers
1 reference
1 reference